The Digisonics' cardiovascular information system (CVIS) system.
News | Cardiovascular Information Systems (CVIS) | December 16, 2020
December 16, 2020 - Intelerad Medical Systems, a provider of enterprise imaging workflow solutions, has acquired...
Videos | FFR Technologies | December 16, 2020
This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a fractional flow...
Videos | Robotic Systems | December 16, 2020
This is an example of the Siemens Corindus CorPath Cath lab robotic system being used for a percutaneous coronary...
The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.

The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease. 

News | FFR Technologies | December 16, 2020
December 16, 2020 – Acist Medical Systems Inc. announced a formal distribution partnership with Medis Medical Imaging...
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist
Feature | Wearables | December 15, 2020
COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office...
Webinar | Information Technology | December 15, 2020
To improve efficiencies in your cardiology department, you need technology to streamline workflows, reduce redundant...
Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) so the company to initiate a U.S. clinical study of its Tria biopolymer mitral surgical heart valve.
News | Heart Valve Technology | December 14, 2020
December 14, 2020 - Foldax Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an...
The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec, 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance.  #COVID #COVID19 #SARSCoV2 #vaccine #COVIDVaccine

The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) Dec. 12 for the COVID-19 vaccine submitted by Pfizer Inc. in partnership with BioNTech Manufacturing GmbH. It is the first mRNA vaccine to gain an FDA clearance and the first COVID vaccine to gain FDA clearance. 

Feature | Coronavirus (COVID-19) | December 14, 2020 | Dave Fornell, Editor
December 14, 2020 — The U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA) for...
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). The  TIVUS System for renal artery denervation treats resistant hypertension, which is defined as blood pressure that remains above 140/90 mmHg despite use of three antihypertensive medications of different classes at the best tolerated doses.

SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

News | Renal Denervation | December 09, 2020
December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to...
Videos | Coronavirus (COVID-19) | December 07, 2020
Todd Hurst, M.D., a cardiologist at Banner University Medicine Heart Institute, and an associate professor at the...
Videos | EP Lab | December 04, 2020
Oussama Wazni, M.D., section head, electrophysiology, Cleveland Clinic, discusses the results of the recent STOP AF...
The Spectrum Dynamics Veriton-CT64 Digital SPECT/CT nuclear imaging system has its SPECT detectors housed in extendable arms to get as close to the patent's chest as possible to improve cardiac perfusion image quality. #RSNA2020 #RSNA20 #RSNA

The Spectrum Dynamics Veriton-CT64 Digital SPECT/CT nuclear imaging system has its SPECT detectors housed in extendable arms to get as close to the patent's chest as possible to improve cardiac perfusion image quality. Photo by Dave Fornell

News | Nuclear Imaging | December 04, 2020
December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for...
Feature | December 03, 2020
View the November-December 2020 digital edition of Diagnostic and Interventional Cardiology (DAIC) magazine, include...
Attune Medical’s ensoETM is a single use thermal regulating device that is placed in the esophagus similar to a standard gastric tube and connected to an external heat exchange unit, creating a closed-loop system for heat transfer to increase or decrease patient temperature. Its placement in the esophagus, with proximity to blood flow from the heart and great vessels, allows highly efficient heat transfer. EPs are now looking at the device as a way to prevent RF damage to the esophagus during ablations.

Attune Medical’s ensoETM is a single use thermal regulating device that is placed in the esophagus similar to a standard gastric tube and connected to an external heat exchange unit, creating a closed-loop system for heat transfer to increase or decrease patient temperature. EPs are now looking at the device as a way to prevent RF damage to the esophagus during cardiac ablations.
 

News | EP Lab | December 03, 2020
December 3, 2020 – Attune Medical reports the first major peer-reviewed clinical publication using its ensoETM device...
An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients. #RSNA2020 #RSNA20 #RSNA

An example of a body composition analysis of an abdominal CT slice with the subcutaneous fat in green, skeletal muscle red and visceral fat in yellow. This was automatically identified and analyzed via a deep learning algorithm to assess the risk for heart attack and stroke in more than 12,000 patients.

Feature | Artificial Intelligence | December 02, 2020
December 2, 2020 – Automated deep learning analysis of abdominal computed tomography (CT) images produces a more...